{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:31:04Z","timestamp":1777393864140,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:00:00Z","timestamp":1647043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007786","name":"National Center for Child Health and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007786","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350\u00a0days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-022-02776-5","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T07:04:33Z","timestamp":1647068673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture"],"prefix":"10.1186","volume":"13","author":[{"given":"Saeko","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Saku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mureo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Kobayshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,12]]},"reference":[{"key":"2776_CR1","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27:R1147\u201351.","journal-title":"Curr Biol"},{"key":"2776_CR2","doi-asserted-by":"crossref","unstructured":"Ponsoda X, Pareja E, G\u00f3mez-Lech\u00f3n MJ, Fabra R, Carrasco E, Trullenque R, et al. Drug biotransformation by human hepatocytes. In vitro\/in vivo metabolism by cells from the same donor. J Hepatol. 2001;34:19\u201325.","DOI":"10.1016\/S0168-8278(00)00085-4"},{"key":"2776_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrgastro.2010.44","volume":"7","author":"A Dhawan","year":"2010","unstructured":"Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7:288\u201398.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2776_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","volume":"63","author":"M Chen","year":"2015","unstructured":"Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol. 2015;63:503\u201314.","journal-title":"J Hepatol"},{"key":"2776_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.celrep.2018.01.087","volume":"22","author":"LT Ang","year":"2018","unstructured":"Ang LT, Tan AKY, Autio MI, Goh SH, Choo SH, Lee KL, et al. A roadmap for human liver differentiation from pluripotent stem cells. Cell Rep. 2018;22:2190\u2013205.","journal-title":"Cell Rep"},{"key":"2776_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/scd.2019.0064","volume":"28","author":"M Zabulica","year":"2019","unstructured":"Zabulica M, Srinivasan RC, Vosough M, Hammarstedt C, Wu T, Gramignoli R, et al. Guide to the assessment of mature liver gene expression in stem cell-derived hepatocytes. Stem Cells Dev. 2019;28:907\u201319.","journal-title":"Stem Cells Dev"},{"key":"2776_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.stem.2014.04.010","volume":"14","author":"A Miyajima","year":"2014","unstructured":"Miyajima A, Tanaka M, Itoh T. Stem\/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell. 2014;14:561\u201374.","journal-title":"Cell Stem Cell"},{"key":"2776_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tcb.2020.01.007","volume":"30","author":"W Li","year":"2020","unstructured":"Li W, Li L, Hui L. Cell plasticity in liver regeneration. Trends Cell Biol. 2020;30:329\u201338.","journal-title":"Trends Cell Biol"},{"key":"2776_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb1625","author":"Y Wei","year":"2021","unstructured":"Wei Y, Wang YG, Jia Y, Li L, Yoon J, Zhang S, et al. Liver homeostasis is maintained by midlobular zone 2 hepatocytes. Science. 2021. https:\/\/doi.org\/10.1126\/science.abb1625.","journal-title":"Science"},{"key":"2776_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4346","author":"L He","year":"2021","unstructured":"He L, Pu W, Liu X, Zhang Z, Han M, Li Y, et al. Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair. Science. 2021. https:\/\/doi.org\/10.1126\/science.abc4346.","journal-title":"Science"},{"key":"2776_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","volume":"15","author":"BD Tarlow","year":"2014","unstructured":"Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell. 2014;15:605\u201318.","journal-title":"Cell Stem Cell"},{"key":"2776_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ncb3203","volume":"17","author":"W-Y Lu","year":"2015","unstructured":"Lu W-Y, Bird TG, Boulter L, Tsuchiya A, Cole AM, Hay T, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971\u201383.","journal-title":"Nat Cell Biol"},{"key":"2776_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.stem.2018.05.022","volume":"23","author":"X Deng","year":"2018","unstructured":"Deng X, Zhang X, Li W, Feng R-X, Li L, Yi G-R, et al. Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes. Cell Stem Cell. 2018;23:114-22.e3.","journal-title":"Cell Stem Cell"},{"key":"2776_CR14","doi-asserted-by":"crossref","unstructured":"Gilgenkrantz H, Collin de l\u2019Hortet A. Understanding liver regeneration: from mechanisms to regenerative medicine. Am J Pathol. 2018;188:1316\u201327.","DOI":"10.1016\/j.ajpath.2018.03.008"},{"key":"2776_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hep.20511","volume":"41","author":"LE Schmidt","year":"2005","unstructured":"Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology Wiley. 2005;41:26\u201331.","journal-title":"Hepatology Wiley"},{"key":"2776_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2016.10.007","volume":"20","author":"T Katsuda","year":"2017","unstructured":"Katsuda T, Kawamata M, Hagiwara K, Takahashi R-U, Yamamoto Y, Camargo FD, et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell. 2017;20:41\u201355.","journal-title":"Cell Stem Cell"},{"key":"2776_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","volume":"23","author":"K Zhang","year":"2018","unstructured":"Zhang K, Zhang L, Liu W, Ma X, Cen J, Sun Z, et al. In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity. Cell Stem Cell. 2018;23:806-19.e4.","journal-title":"Cell Stem Cell"},{"key":"2776_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47313","author":"T Katsuda","year":"2019","unstructured":"Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto-Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.47313.","journal-title":"Elife"},{"key":"2776_CR19","doi-asserted-by":"publisher","first-page":"11381","DOI":"10.1038\/s41598-021-90708-3","volume":"11","author":"R Tsuneishi","year":"2021","unstructured":"Tsuneishi R, Saku N, Miyata S, Akiyama S, Javaregowda PK, Ite K, et al. Ammonia-based enrichment and long-term propagation of zone I hepatocyte-like cells. Sci Rep. 2021;11:11381.","journal-title":"Sci Rep"},{"key":"2776_CR20","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1002\/stem.2457","volume":"34","author":"N Tanimizu","year":"2016","unstructured":"Tanimizu N, Ichinohe N, Ishii M, Kino J, Mizuguchi T, Hirata K, et al. Liver progenitors isolated from adult healthy mouse liver efficiently differentiate to functional hepatocytes in vitro and repopulate liver tissue. Stem Cells. 2016;34:2889\u2013901.","journal-title":"Stem Cells"},{"key":"2776_CR21","doi-asserted-by":"publisher","first-page":"e0162693","DOI":"10.1371\/journal.pone.0162693","volume":"11","author":"D Tomotsune","year":"2016","unstructured":"Tomotsune D, Hirashima K, Fujii M, Yue F, Matsumoto K, Takizawa-Shirasawa S, et al. Enrichment of pluripotent stem cell-derived hepatocyte-like cells by ammonia treatment. PLoS ONE. 2016;11:e0162693.","journal-title":"PLoS ONE"},{"key":"2776_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13287-021-02680-4","volume":"13","author":"S Miyata","year":"2022","unstructured":"Miyata S, Saku N, Akiyama S, Javaregowda PK, Ite K, Takashima N, et al. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI). Stem Cell Res Ther. 2022;13:6.","journal-title":"Stem Cell Res Ther"},{"key":"2776_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1073\/pnas.45.12.1721","volume":"45","author":"MB Yarmolinsky","year":"1959","unstructured":"Yarmolinsky MB, Haba GL. Inhibition by puromycin of amino acid incorporation into protein. Proc Natl Acad Sci U S A. 1959;45:1721\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2776_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/nar\/28.5.1176","volume":"28","author":"E Miyamoto-Sato","year":"2000","unstructured":"Miyamoto-Sato E, Nemoto N, Kobayashi K, Yanagawa H. Specific bonding of puromycin to full-length protein at the C-terminus. Nucleic Acids Res. 2000;28:1176\u201382.","journal-title":"Nucleic Acids Res"},{"key":"2776_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.csbj.2020.04.014","volume":"18","author":"R Aviner","year":"2020","unstructured":"Aviner R. The science of puromycin: from studies of ribosome function to applications in biotechnology. Comput Struct Biotechnol J. 2020;18:1074\u201383.","journal-title":"Comput Struct Biotechnol J"},{"key":"2776_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4939-6506-9_16","volume-title":"Hepatocyte transplantation: methods and protocols","author":"S Enosawa","year":"2017","unstructured":"Enosawa S. Isolation of GMP grade human hepatocytes from remnant liver tissue of living donor liver transplantation. In: Stock P, Christ B, editors. Hepatocyte transplantation: methods and protocols. New York, NY: Springer; 2017. p. 231\u201345."},{"key":"2776_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12347","author":"G Sugahara","year":"2020","unstructured":"Sugahara G, Yamasaki C, Yanagi A, Furukawa S, Ogawa Y, Fukuda A, et al. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency. J Inherit Metab Dis. 2020. https:\/\/doi.org\/10.1002\/jimd.12347.","journal-title":"J Inherit Metab Dis"},{"key":"2776_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/lt.23800","volume":"20","author":"S Enosawa","year":"2014","unstructured":"Enosawa S, Horikawa R, Yamamoto A, Sakamoto S, Shigeta T, Nosaka S, et al. Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes. Liver Transpl. 2014;20:391\u20133.","journal-title":"Liver Transpl"},{"key":"2776_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","volume":"29","author":"S Yachida","year":"2016","unstructured":"Yachida S, Wood LD, Suzuki M, Takai E, Totoki Y, Kato M, et al. Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma. Cancer Cell. 2016;29:229\u201340.","journal-title":"Cancer Cell"},{"key":"2776_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"2776_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2014.12.004","volume":"1","author":"H Akutsu","year":"2015","unstructured":"Akutsu H, Machida M, Kanzaki S, Sugawara T, Ohkura T, Nakamura N, et al. Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells. Regen Ther. 2015;1:18\u201329.","journal-title":"Regen Ther"},{"key":"2776_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/science.aau7307","volume":"364","author":"C Xiang","year":"2019","unstructured":"Xiang C, Du Y, Meng G, Soon Yi L, Sun S, Song N, et al. Long-term functional maintenance of primary human hepatocytes in vitro. Science. 2019;364:399\u2013402.","journal-title":"Science"},{"key":"2776_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature22306","volume":"545","author":"CY Janda","year":"2017","unstructured":"Janda CY, Dang LT, You C, Chang J, de Lau W, Zhong ZA, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and \u03b2-catenin signalling. Nature. 2017;545:234\u20137.","journal-title":"Nature"},{"key":"2776_CR34","doi-asserted-by":"crossref","unstructured":"Yanagida A, Ito K, Chikada H, Nakauchi H, Kamiya A. An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential. PLoS One. 2013;8:e67541.","DOI":"10.1371\/journal.pone.0067541"},{"key":"2776_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2011.02741.x","volume":"32","author":"H Ito","year":"2012","unstructured":"Ito H, Kamiya A, Ito K, Yanagida A, Okada K, Nakauchi H. In vitro expansion and functional recovery of mature hepatocytes from mouse adult liver. Liver Int. 2012;32:592\u2013601.","journal-title":"Liver Int"},{"key":"2776_CR36","unstructured":"Food and Drug Administration. Current Good Tissue Practice. 2021;21CFR1271.210."},{"key":"2776_CR37","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: Current good tissue practice (CGTP) and additional requirements for manufacturers of human cells, tissues, and cellular and tissue-based products (HCT\/Ps). Guidance for Industry. 2011."},{"key":"2776_CR38","first-page":"32","volume":"49","author":"E Commission","year":"2006","unstructured":"Commission E. Commission directive 2006\/86\/EC. Off J Eur Union. 2006;49:32\u201350.","journal-title":"Off J Eur Union"},{"key":"2776_CR39","unstructured":"European Medicines Agency. ICH Q5A (R1) Quality of biotechnological products:Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin (Step 5). 1997;CPMP\/ICH\/295\/95."},{"key":"2776_CR40","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1021\/ci300367a","volume":"52","author":"F Cheng","year":"2012","unstructured":"Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G, et al. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52:3099\u2013105.","journal-title":"J Chem Inf Model"},{"key":"2776_CR41","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372.","journal-title":"Nucleic Acids Res"},{"key":"2776_CR42","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. Oxford University Press; 2018;46:D1074\u201382.","DOI":"10.1093\/nar\/gkx1037"},{"key":"2776_CR43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/cr.2017.47","volume":"27","author":"H Wu","year":"2017","unstructured":"Wu H, Zhou X, Fu G-B, He Z-Y, Wu H-P, You P, et al. Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion. Cell Res. 2017;27:709\u201312.","journal-title":"Cell Res"},{"key":"2776_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/liv.12577","volume":"35","author":"C Cicchini","year":"2015","unstructured":"Cicchini C, Amicone L, Alonzi T, Marchetti A, Mancone C, Tripodi M. Molecular mechanisms controlling the phenotype and the EMT\/MET dynamics of hepatocyte. Liver Int. 2015;35:302\u201310.","journal-title":"Liver Int"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-02776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-02776-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-02776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T07:12:56Z","timestamp":1647069176000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-02776-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2776"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-02776-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.18.440311","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,12]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human cells in this study were performed in full compliance with the Ethical Guidelines for Clinical Studies (Ministry of Health, Labor, and Welfare, Japan). The cells were banked after approval of the Institutional Review Board at the National Institute of Biomedical Innovation (May 9, 2006). Animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of the National Research Institute for Child Health and Development.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from the patient's parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AU is a co-researcher with MTI Ltd., Terumo Corp., BONAC Corp., Kaneka Corp., CellSeed Inc., ROHTO Pharmaceutical Ltd., SEKISUI MEDICAL Ltd., Metcela Inc., PhoenixBio Ltd., Dai Nippon Printing Ltd. AU is a stockholder of TMU Science Ltd., Morikuni Ltd. and Japan Tissue Engineering Ltd. AU is the associate editor of the journal and was not involved in the peer review process of the article. The other authors declare that there is no conflict of interest regarding the work described herein.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}